Announcements Trials
Browse Landscape

Status

Completed 456Recruiting 171Terminated 169Active not recruiting 83Unknown 62Not yet recruiting 28Withdrawn 22Suspended 5Available 3No longer available 2Enrolling by invitation 2Approved for marketing 2Temporarily not available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Uterine Neoplasms 1Uterine Cervical Neoplasms 1Sarcoma, Ewing 1Prostatic Neoplasms, Castration-Resistant 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Myelodysplastic Syndromes 1Locally Advanced Pancreatic Adenocarcinoma 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Hematologic Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

FANG vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Temporarily not available × INDUSTRY × Ovarian Neoplasms × Clear all
NCT03842865 2025-06-05

Expanded Access of Vigil in Solid Tumors

Gradalis, Inc.

Temporarily not available
GynecologicSarcoma

Uterine Cervical Neoplasms, Ovarian Neoplasms, Sarcoma, Ewing, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡